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ABSTRACT 
Background: The development of continuous curvilinear capsulorrhexis 
(CCC) has contributed significantly to the tolerability and effectiveness of cataract 
extraction and intraocular lens implantation. Staining of the anterior capsule has 
become a popular method of increasing visibility when performing CCC. 
Objective: The aim of this study was to determine, using scanning electron 
microscopy (SEM) and transmission electron microscopy (TEM), the highest 
concentrations of trypan blue dye that would not cause long-term toxicity after 
injection into the anterior chamber of rat eyes. 
Methods: The eyes of healthy female albino Wistar rats were used in this 
investigator-masked, controlled, 2-period, experimental study conducted over 
12 weeks at the Dicle University Experimental Animal Laboratory, Diyarbaklr, 
Turkey. The rats were randomly divided into 5 groups of 4 using a random- 
number table. Each rat was administered a 0.05-mL injection of trypan blue 
into the right eye in 1 of the following concentrations: 0.4%, 0.2%, 0.1%, 0.05%, 
or 0.025%. A 0.05-mL pH-balanced saline solution was injected into the left 
eye of each rat to act as a control. At 1 day after injection and 4 weeks after 
injection (early period), 1 rat from each concentration group was euthanized 
and their eyes were enucleated. At 12 weeks after injection (late period) the 
remaining 2 rats from each group were euthanized and their eyes were enu- 
cleated. Corneal endothelial cells and the anterior lens capsule of the enucle- 
ated eyes were analyzed using SEM and TEM, and the results were compared 
with those of the control group. In the TEM analysis, the primary end point 
was the histopathologic changes in the cellular organelles when compared 
with those in the control group. In the SEM analysis, the primary end point 
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was changes in cell shape, intracellular junctions, and density of the microvilli 
when compared with those in the control group. 
Results: Forty eyes from 20 albino Wistar rats (mean [SD] age, 8.2 [ 1.6] weeks; 
mean [SD] weight, 175.6 [16.5] g) were used in the study. Each group of rats 
received a different concentration of trypan blue in the right eye. In the early 
period, both the 0.4% and 0.2% concentrations were associated with the impair- 
ment of the hexagonal structure of corneal endothelial cells and intercellular 
junctions. Those concentrations were also associated with an increased occur- 
rence of cellular vacuolation, cytoplasmic edema, extensive granulation of the 
endoplasmic reticulum, pyknotic nuclei, and mitochondrial degeneration. In the 
late period, these changes were observed as persisting in a decreasing manner. 
With the 0.1% and 0.05% concentrations, the density of microvilli decreased, 
nuclei appeared normal, granulation of the endoplasmic reticulum and Golgi 
apparatus was active, and minimal levels of mitochondrial degeneration were 
observed. 
Conclusions: In this small experimental study in rat eyes, trypan blue at 
concentrations >0.025% was associated with impaired morphology and struc- 
ture of corneal endothelial cells after short-term exposure. This effect contin- 
ued in a decreasing fashion after long-term exposure. No significant changes 
were noted in the control group or the group administered the 0.025% concen- 
tration. (Curr Ther Res Clin Exp. 2006;67:366-377) Copyright © 2006 Excerpta 
Medica, Inc. 
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INTRODUCTION 
Continuous curvilinear capsulorrhexis (CCC) has contributed significantly to 
the tolerability and effectiveness of cataract extraction and intraocular lens 
implantation. 1 This surgical technique produces a strong rim on the anterior 
capsule that resists tearing, even when stretched during crystalline lens 
removal or intraocular lens implantation. 1,2 It also ensures reliable intraocu- 
lar lens centration in the capsular bag. However, accurate capsulorrhexis 
might be difficult to achieve, particularly in eyes with mature, intumescent 
cataracts. In those cases, the surgeon may have difficulty seeing the advanc- 
ing edge of the capsulotomy because of the absence of red reflex when 
retroilluminated. 3 Poor visualization of the capsule may result in an inade- 
quate CCC; high risk for radial tears toward or beyond the lens equator; and 
complications such as zonular and posterior capsule tears, vitreous loss, and 
intraocular lens decentration. 1,4 
Staining of the anterior capsule has become a popular method of increas- 
ing visibility when performing CCC. Many staining agents have been used 
to date, including autologous blood and a variety of dyes 5 (eg, indocyanine 
green, 6gentian violet, 7 methylene blue, 8 subcapsular fluorescein, and trypan 
blue). 
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Although many pigments have been used to enhance visualization during 
cataract surgery, complications have been found with the use of some of these 
dyes. Corneal edema has been reported with 0.1% gentian violet and 1% meth- 
ylene blue. 9,1° Because fluorescein is administered under the capsule, it stains 
the cortex as well as the capsule. Thus, the capsule is difficult to distinguish 
from the cortex, and a blue filter is needed. 11 Nahra and Castilla 12 injected 2% 
fluorescein into the anterior side of the capsule under air and reported that 
blue light was not required uring surgery. They also reported that fluorescein 
at that concentration might be toxic to the endothelium. In the study by Melles 
et al, 9 in 30 human patients with mature cataracts, 0.1 mL of trypan blue 0.1% 
was found to have no toxic effects after 12 months of follow-up. 
Trypan blue is a blue bis-azo dye. The trypan blue molecules are symmetric, 
consisting of 3 main parts connected by 2 azo bonds. As early as 1967, trypan 
blue was used to stain the cornea and conjunctiva. 13It has also been used to 
examine ndothelial cells after cataract surgery and in donor corneal grafts 
without any documented adverse vents. 14 
Bis-azo dyes, such as trypan blue, stain poorly hydrated tissues better than 
well-hydrated ones. 15 The lens cortex, which consists of lens fibers, has a high 
water content compared with the acellular basement membrane, 16 which ex- 
plains why the dye stains the basement membrane without clinically significant 
staining of the lens cortex. This results in marked color contrast between these 
2 structures. The resulting high visibility of the lens capsule allows the surgeon 
to precisely distinguish it from the underlying cortex during capsulorrhexis 
for phacoemulsification of the lens. :7 Because the visibility of the anterior cap- 
sule is enhanced with trypan blue, this dye is sometimes used when teaching 
capsulorrhexis to surgeons in training. 18 
Despite changes in staining techniques, trypan blue is the preferred ye in 
modern cataract surgery. 19 Trypan blue is kept in the anterior chamber for a 
short time and the chamber is then irrigated before CCC is performed. Thus, in 
the clinical setting, trypan blue remains in the eye for a short time period. 
Although trypan blue is reported to be nontoxic to ocular structures over a 
short period, it is on the list of carcinogenic chemicals in The Merck Index. 2° In 
addition, its long-term effects are unknown, and it should be used carefully in 
certain groups (eg, pediatric and pregnant patients). 21
The aim of this study was to determine the highest concentrations of trypan 
blue dye that would not cause long-term toxicity after injection into the anterior 
chamber of rat eyes. Scanning electron microscopy (SEM) and transmission 
electron microscopy (TEM) were used to assess histopathologic and morphologic 
changes in the corneal endothelium and anterior lens capsule. 
MATERIALS AND METHODS 
Healthy female albino Wistar rats that were free of clinical eye disease were 
used in this 12-week, investigator-masked, controlled, 2-period, experimental 
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study. All of the rats were obtained from and housed at the Dicle University 
Experimental Animal Laboratory, Diyarbaklr, Turkey, and assessed before the 
study by 2 independent ophthalmologists. 
All experimental procedures were approved by the Ethics Committee for 
Experimental Animals at Dicle University and were performed according to the 
Association for Research in Vision and Ophthalmology Statement 22 for the use 
of animals in ophthalmic and vision research. 
All procedures were performed by the same surgeon (I.(~.). The rats were ran- 
domly assigned using a random-number table to receive trypan blue at 1 of 
5 concentrations: 0.4%, 0.2%, 0.1%, 0.05%, or 0.025%. The rats were anesthetized 
with IM injections of ketamine hydrochloride 30 mg/kg. An operating micro- 
scope (OPMI-8, Carl Zeiss, Gottingen, Germany) was positioned over the eye 
undergoing surgery. The anterior chamber was entered in the superotemporal 
quadrant hrough a corneal tunnel using a 28-gauge insulin syringe for dye 
administration. Each rat was administered a 0.05-mL injection of trypan blue 
into the right eye at the assigned concentration. A 0.05-mL pH-balanced saline 
solution (BSS) was inject-ed into the left eye of each rat to act as a control. 
At 1 day after injection and 4 weeks after injection (early period), 1 rat 
from each concentration group was euthanized and their eyes were enucleated. 
At 12 weeks after injection (late period), the remaining 2 rats from each group 
were euthanized and their eyes enucleated. 
Corneas were completely removed with the aid of an operating microscope. 
Corneal buttons were cut into 2 equal halves. One half was prepared for SEM 
analysis and the other half was prepared for TEM analysis. The anterior lens 
capsule was removed using the CCC method. Histologic hanges in the anterior 
lens capsule were assessed using SEM (LEO 440, Leica Zeiss, K61n, Germany) 
and TEM (JEOL 1010, Jeol Ltd., Tokyo, Japan). 
In the TEM analysis, the histopathologic changes in the cellular organelles 
were compared with those in the control group. In the SEM analysis, changes in 
cell shape, intracellular junctions, and density of the microvilli were also com- 
pared with those in the control group. 
In regard to the group to which the eyes were assigned, investigators per- 
forming SEM and TEM analysis were masked. 
RESULTS 
Twenty albino Wistar rats were included in the study (mean [SD] age, 8.2 
[1.6] weeks; mean [SD] weight, 175.6 [16.5] g) (4 rats per study group). 
SEM Analysis 
Morphologic analysis, in the early period, with SEM revealed that with try- 
pan blue 0.4% and, to a lesser degree, 0.2%, the hexagonal structure of corneal 
endothelial cells and the intercellular junctions were impaired and microvilli 
and cellular surfaces were destroyed, whereas in the control group they were 
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not (Figures 1 and 2). In the late period, in the same 2 groups, the hexagonal 
structure of endothelial cells had been restored and the intercellular junctions 
and regenerated microvilli were visible in some places. In the early period, in 
the eyes treated with 0.1% and 0.05% concentrations, normal hexagonal struc- 
ture of the endothelial cells and intercellular junctions was observed; however, 
the density of the microvilli was decreased. In the late period, compared with 
the control group, persistence of the decreased ensity of the microvilli was 
observed (Figure 3). No significant difference with respect o endothelial cells 
or density of microvilli was observed in the eyes treated with trypan blue 
0.025% compared with those in the control group. 
Early-period morphologic analysis of the lens epithelium using SEM revealed 
loss of cellular borders and microvilli, and degeneration f epithelial cells with pro- 
truded nuclei in the 0.4%, 0.2%, and 0.1% groups, with the changes being most 
noticeable in the 0.4% group (F'~uure 4). In the late period, in the 0.2%- and 0.1%- 
concentration groups, microvilli were visible in some places. In the early period, 
in the 0.05%- and 0.025%-concentration groups, cellular borders and microvilli 
appeared normal, while porous and cytoplasmic constrictions were found in some 
epithelial cell membranes. These effects were less evident in the late period. 
TEM Analysis 
Ultrastructural nalysis with TEM revealed pyknotic orneal endothelial cell 
nuclei in the trypan blue 0.4% and 0.2% groups but not in the control group. 
Degeneration f cellular organelles, cellular vacuolation, intracytoplasmic edema, 
granulation of endoplasmic reticulum, and mitochondrial degeneration were 
also noticeable in the 0.4% and 0.2% groups (Figures 5 and 6). In the late period, 
cells were further flattened, nuclei were euchromatic, ellular vacuolation and 
mitochondrial degeneration had decreased, and i tercellular side junctions 
were normal. In the early and late periods in the groups administered trypan 
blue 0.1% and 0.05%, the nuclei appeared normal, granulated endoplasmic retic- 
ulum and Golgi were active, and there were minimal evels of mitochondrial 
degeneration (Figure 7). 
No difference in either the early or late period was found in the 0.025%- 
concentration group when compared with the control group. 
DISCUSSION 
The results of this study suggest that intraocular use of high concentrations of 
trypan blue are associated with irreversible toxic effects in both the short term 
and the long term. Toxic effects occurring in the short term with the 0.1% and 
0.05% concentrations were found to have decreased in the long term. The rea- 
son for this is thought o be that intraocular fluid production might decrease 
the drug concentration a d the drug is flushed from the eye via drainage by the 
Schlemm channel. 23 This study also suggests that the 0.025% concentration of
trypan blue is not associated with any toxic effects in the short or long term. 
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Figure 1. Appearance of corneal endothelial cells in the control group using scanning 
electron microscopy 1 day after injection of 0.05 mL of pH-balanced saline 
solution into the anterior chamber of a rat's eye (the hexagonal structure of 
the cells and intercellular junctions are normal and microvilli on the cell sur- 
face are visible). (Magnification rate: Original magnification × 2250. Scale: 
1 inch = 10 pm.) 
Figure 2. Appearance of corneal endothelial cells using scanning electron microscopy 
1 day after injection of 0.05 mL of trypan blue 0.4% into the anterior cham- 
ber of a rat's eye (the hexagonal structure of the cells, the intercellular junc- 
tions, and the microvilli on the cell surface are not visible). (Magnification 
rate: Original magnification × 2500. Scale: 1 inch -- 10 pm.) 
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Figure 3. Appearance of corneal endothelial cells using scanning electron microscopy 
12 weeks after injection of 0.05 mL of trypan blue 0.1% into the anterior 
chamber of a rat's eye (the hexagonal structure of the cells and intercellular 
junctions are visible, but microvillar intensity on the cell surface is decreased). 
(Magnification rate: Original magnification × 2250. Scale: 1 inch = 10 pm.) 
Figure 4. Appearance of lens epithelium using scanning electron microscopy 1 day 
after injection of 0.05 mL of trypan blue 0.4% into the anterior chamber of 
a rat's eye (loss of lens epithelial cell borders and microvilli and degener- 
ated epithelial cells with protruded nuclei are seen). (Magnification rate: 
Original magnification × 1000. Scale: 0.5 inch = 10 pm.) 
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Figure 5. Appearance of mitochondria (M), granulated endoplasmic reticulum (GER), 
and nuclei (N) of the corneal endothelium in the control group using trans- 
mission electron microscopy I day after injection of 0.05 mL of pH-balanced 
saline solution into the anterior chamber of a rat's eye. (Uranyl acetate and 
lead citrate, original magnification × 4400.) 
The most sensitive methods for determining changes that occur at the cellu- 
lar level are SEM and TEM. 24 We believed that using SEM and TEM to analyze 
cellular structural changes associated with the use of trypan blue dye might 
improve the reliability of the study results. 
Van Dooren et a125 used specular microscopy to analyze corneal endotheli- 
al cells of patients after phacoemulsification. The patients were divided into 
2 groups, 1 of which was administered 0.06% trypan blue and the other was not. 
They reported that no difference in toxic effects of the corneal endothelium was 
observed between the 2 groups and, therefore, 0.06% trypan blue was not asso- 
ciated with any toxic effects on corneal endothelium. 
In our study, trypan blue was left in the eye for up to 12 weeks to determine 
whether long-term exposure to the dye was toxic to intraocular tissues. To our 
knowledge (Web of Science search; all years, all languages; key terms: trypan 
blue, corneal endothelium, SEM and TEM), this is the first report in which try- 
pan blue was injected into the anterior chamber and the corneal endothelium 
was then assessed using SEM and TEM. 
In a study by Jongebloed et al, 26 lens capsules from patients of advanced age, 
obtained after extracapsular cataract surgery, were prepared for a combined 
light microscopy, TEM, and SEM investigation. Using SEM, they were able to 
observe protruded nuclei in degenerated lens capsule epithelium compared 
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Figure 6. Appearance of corneal endothelial cells using transmission electron micros- 
copy 1 day after injection of trypan blue 0.4% into the anterior chamber 
of a rat's eye (large and small vacuoles IV], extensive granulation of endo- 
plasmic reticulum [~1], pyknotic nuclei [PN], and common degeneration in 
mitochondria [*] were observed). (Uranyl acetate and lead citrate, original 
magnification × 4400.) 
with healthy lens capsule pithelium (obtained from clear lens surgery patients 
at the same facility) and determined that some nuclei were completely detached 
from the cytoplasm. In our study, loss of epithelial cell borders and microvilli 
and degenerated pithelial cells with protruded nuclei were most evident in the 
0.4% group, and were also observed in the 0.2% and 0.1% groups. Porous epithe- 
lial cell membranes and cytoplasmic constriction were observed in the 0.05% 
and 0.025% groups. 
Washing the anterior chamber with BSS soon after injecting trypan blue after 
protecting the corneal endothelium with sterile air has been associated with a 
reduction in toxic effects in human eyes. 19 Because the aim of our study was to 
determine the highest concentration of trypan blue that would not be toxic for 
ocular use, intraocular air administration and irrigation of the trypan blue dye 
were not performed. Future studies might use the procedures and results from 
this study to perform a longer-term comparison of changes. 
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Figure 7. Appearance of corneal endothelial cells using transmission electron mi- 
croscopy 12 weeks after injection of trypan blue 0.1% into the anterior 
chamber of a rat's eye (mitochondria [M] and nuclei IN] appeared normal, 
granulated endoplasmic reticulum [GER] and Golgi [G] were active, and 
mitochondrial degeneration [*] was observed). (Uranyl acetate and lead 
citrate, original magnification x 4400.) 
CONCLUSIONS 
In this small experimental study in rat eyes, trypan blue at concentrat ions 
>0.025% was associated with impaired morphology and structure of corneal 
endothelial cells after short-term exposure. This effect continued in a decreas- 
ing fashion after long-term exposure. No significant changes were noted in the 
control group or the group administered the 0.025% concentration. The use of 
SEM and TEM in the analysis process was instrumental to observing all changes 
on the cellular level. 
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